Quick Answer
Compounded semaglutide costs $179 for the first month and $249 to $399 per month after in 2026 through US-licensed telehealth providers, depending on the form (sublingual or injection), the provider, and the commitment tier.
Compounded medications are not FDA-approved as final products and are not generic versions of, or interchangeable with, any brand-name medication.
Compounded preparations are not FDA-approved as final products. The active pharmaceutical ingredient meets United States Pharmacopeia (USP) standards. The price difference reflects production cost, not lower quality at accredited pharmacies.
2026 Compounded Semaglutide Pricing (Real Numbers)
Pricing verified June 2026 against each provider's published pricing page. Re-verify quarterly; telehealth pricing changes frequently. All prices reflect cash pricing without insurance, in USD.
| Provider | Plan | First month | Ongoing | All-inclusive? |
|---|---|---|---|---|
| Majesta Health | Essential (semaglutide injection) | $179 | $299/month | Yes (physician, medication, shipping, messaging) |
| Medvi | Compounded semaglutide injection | $179 | $299/month | Single plan structure |
| Henry Meds | Compounded semaglutide | $149 to $297/month | Same | Multiple commitment tiers |
| Mochi Health | Compounded semaglutide injection | $99 to $290/month | Tiered by commitment | Membership model |
| Calibrate | Coaching + medication bundle | $199/month + $1,649 annual fee | First-month total ~$1,848 | Annual contract required |
2026 market shift you should know about. Two of the largest telehealth names adjusted their compounded offerings in 2025-2026. Hims & Hers moved away from compounded semaglutide in early 2026, and Ro pivoted to brand-name GLP-1 only. That leaves the compounded market to focused providers like Majesta Health, Medvi, Henry Meds, and Mochi. If you see an old article listing Hims or Ro compounded pricing, it is out of date.
For a broader provider-by-provider comparison see our cheapest semaglutide online in 2026 guide.
Brand-Name Comparison
Brand-name semaglutide is a separate, FDA-approved category. For consumer reference, here are the published cash prices as of June 2026 (manufacturer list prices; verify current figures with the manufacturer):
| Brand | Manufacturer | Cash price per month | Indication |
|---|---|---|---|
| Wegovy | Novo Nordisk | ~$1,349 | FDA-approved for weight loss + (since 2024) cardiovascular risk reduction in adults with CVD and overweight or obesity |
| Ozempic | Novo Nordisk | ~$968 to $1,150 | FDA-approved for type 2 diabetes; often prescribed off-label for weight loss |
| Rybelsus | Novo Nordisk | ~$1,029 | FDA-approved oral semaglutide for type 2 diabetes only |
Manufacturer savings programs:
With commercial insurance coverage, copays for brand-name semaglutide can be as low as $25 to $100 per month when approved (often requires prior authorization with documented BMI and comorbidity criteria).
With no insurance coverage, compounded semaglutide through legitimate US-licensed telehealth is consistently the most affordable real path.
What the Price Should Include
The headline price is only meaningful if you know what is bundled. A $99 plan that bills consultation, shipping, and refills separately can easily cost more than a $179 plan with everything included.
A legitimate compounded semaglutide plan in 2026 ($179 first month, $249 to $399 per month ongoing) should include:
What should NOT be hidden in the fine print:
Insurance and HSA / FSA Reality (2026)
Commercial insurance almost never covers compounded semaglutide. Coverage for brand-name (Wegovy or Ozempic) is variable, with most weight-loss-indication coverage requiring prior authorization and documented BMI plus comorbidity criteria. Coverage for Ozempic for diabetes is generally broader.
Medicare does not cover GLP-1s for weight loss as of 2026. Medicare Part D covers Ozempic for diabetes indication.
Medicaid varies by state. Many state programs cover GLP-1s for diabetes only.
HSA and FSA cards typically reimburse prescription compounded semaglutide when accompanied by valid documentation. Save your prescription confirmation and pharmacy receipts.
The All-In Six-Month Math
This is the comparison that matters for cash-paying patients planning treatment.
| Plan | Month 1 | Months 2-6 | Total six-month | Average / month |
|---|---|---|---|---|
| Majesta Essential (injection) | $179 | $299 × 5 = $1,495 | $1,674 | $279 |
| Other compounded providers (mid-tier $299/mo) | $299 | $299 × 5 = $1,495 | $1,794 | $299 |
| Calibrate annual program + medication | $1,649 + $199 | $199 × 5 = $995 | $2,843 | $474 |
Totals assume monthly billing; see each provider's billing policy for cycle details. This table compares compounded telehealth programs only; brand-name pricing is published by the manufacturers and depends on coverage.
Why Pricing Should Not Be the Only Factor
Three factors matter as much as price when evaluating any compounded semaglutide source:
1. Is the prescribing physician real and US-licensed? Cheap sources often skip this. Skipping medical screening is the actual safety risk. 2. Is the dispensing pharmacy accredited? A 503A or 503B pharmacy with NABP accreditation and LegitScript certification, that batch-tests every preparation for potency and sterility, operates at a much higher safety standard than an unaccredited one. 3. Is ongoing physician access included? Side effects and dose adjustments happen for almost every patient in the first 2 to 3 months. Without a physician you can message, you handle them alone.
For a deeper look at how to verify a compounded semaglutide source, see our safety guide.
Red Flags: Pricing Below the Market Floor
Legitimate compounded semaglutide pricing in 2026 has a floor around $100 to $150 per month for ongoing supply. Providers offering ongoing compounded semaglutide below that price are almost always cutting one of these:
None of these are safe paths. They also create real legal risk for the buyer in addition to product quality risk.
The true price floor reflects the real cost of active pharmaceutical ingredient sourcing, accredited pharmacy compounding, batch testing, US physician oversight, and HIPAA-compliant infrastructure. Below that floor, something is being skipped.
The Bottom Line
In 2026, compounded semaglutide costs $179 for the first month and $249 to $399 per month after through US-licensed telehealth providers, all-in. Brand-name routes have their own pricing, published by the manufacturers, and with insurance coverage brand-name copays can win on math, though coverage for weight loss is patchy and often requires prior authorization. Compare documented totals for your own situation.
Majesta Health's flagship plan is compounded semaglutide injection at $179 your first month, then $299 per month, all-in. Compounded preparations are not FDA-approved as final products; the active pharmaceutical ingredient meets United States Pharmacopeia (USP) standards.
The number that matters is not the headline. It is the all-in monthly cost at a provider with a real US-licensed physician, an accredited compounding pharmacy, and ongoing physician access included.
If you want a physician-reviewed recommendation specific to your situation, start your 2-minute medical assessment at /quiz. A US-licensed physician will review your information, screen for contraindications, and confirm the right plan for you.
Related guides
This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider. Compounded medications are not FDA-approved as final products. Prices reflect typical 2026 US retail and are subject to change. Individual results may vary.
Frequently Asked Questions
How much does compounded semaglutide cost per month in 2026?
Through US-licensed telehealth providers, compounded semaglutide costs $179 for the first month and typically $249 to $399 per month after in 2026. Sublingual semaglutide is the most affordable at $179 to $249 per first month. Injection semaglutide runs $179 the first month and $249 to $399 per month after, depending on provider and commitment tier, with the physician consultation, medication, and shipping typically bundled. Compounded medications are not FDA-approved as final products.
Why is compounded semaglutide priced the way it is?
Compounded semaglutide contains an active pharmaceutical ingredient that meets United States Pharmacopeia (USP) standards, prepared in small, patient-specific batches at state-licensed 503A or 503B compounding pharmacies. The monthly price reflects ingredient and preparation cost plus the bundled physician consultation and shipping, set by each provider. It is a separate category from FDA-approved brand medications, whose prices are set by the manufacturers and depend on coverage. The trade-off is that the compounded preparation itself is not FDA-approved as a final product and is not a generic version of, or interchangeable with, any brand product.
What should be included in the monthly compounded semaglutide price?
The all-in monthly price from a legitimate provider should include: the compounded semaglutide medication itself, the physician consultation and prescription (with any medical consultation fee disclosed upfront), discreet shipping in plain packaging, and ongoing physician messaging access for dose adjustments and side-effect questions. The headline price is only meaningful when these are bundled. A $99 plan that bills consultation, shipping, and messaging separately often costs more all-in than a $179 plan with everything included.
Does insurance cover compounded semaglutide?
Compounded semaglutide is almost never covered by commercial insurance, Medicare, or Medicaid; it is a cash-pay program with one bundled monthly price. HSA and FSA cards are typically accepted by US-licensed telehealth providers with a valid prescription. If insurance covers a brand-name product at a low copay, the covered brand route can win on math. Compare your documented out-of-pocket cost on any covered option against the all-in compounded cash price.
What hidden fees should I watch for when comparing compounded semaglutide prices?
Watch for separate consultation fees, shipping fees, refill fees, lab work fees, multi-month prepay requirements to access the published cheapest tier, plan cancellation penalties, paid coaching tiers bundled with the medication, and undisclosed dose-escalation upcharges. The legitimate way to compare providers is to compute the total first-month cost including any one-time fees, and the total ongoing monthly cost with no commitment.
Is there a price below which compounded semaglutide becomes unsafe?
Roughly yes. Legitimate cash pricing in 2026 has a floor around $100 to $150 per month. Providers offering ongoing compounded semaglutide below that price are almost always cutting one of three required steps: skipping real medical screening, using an unregulated pharmacy (often offshore), or selling as 'research peptides' without a prescription. Each of those creates real safety and legal risk. The true price floor reflects the real cost of active pharmaceutical ingredient, accredited pharmacy compounding, batch testing, and physician oversight.
Majesta Health medical content is written against primary sources (FDA labels, peer-reviewed trials, HHS and CDC publications) and passes a documented compliance review before publication. We are rolling out named physician review with US-licensed clinicians from our partner MD Integrations (MDI): each reviewed article will show the reviewing physician's name, NPI, and review date. MDI is LegitScript certified and SOC 2 Type II accredited.
- US-licensed physicians affiliated with our clinical partner MD Integrations (LegitScript certified, HIPAA, SOC 2 Type II, ISO certified)
- Board-certified in primary care and obesity medicine
- Active state medical licensure required for every prescribing clinician
- Active DEA registration where applicable (note: GLP-1 medications are not controlled substances)
- Telehealth practice across the states we currently serve through the MD Integrations Medical Services Organization (coverage varies by state; see our states page)
- Dispensing pharmacy partner: Belmar Pharma Solutions (LegitScript certified, NABP accredited); Majesta prescriptions are dispensed through Belmar's state-licensed 503A compounding pharmacy